4//SEC Filing
Miller Steve 4
Accession 0001161697-24-000542
CIK 0001369568other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 4:30 PM ET
Size
7.6 KB
Accession
0001161697-24-000542
Insider Transaction Report
Form 4
Miller Steve
VP Development & Management
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-12-27−14,000→ 1,538,176 total→ Common Stock (14,000 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2024-12-27+14,000→ 935,996 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
- [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 27, 2024.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001402535
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 4:30 PM ET
- Size
- 7.6 KB